Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Other
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Preclinical/no trial
- ChEMBL max phase
- -1 / 4 (development scale, not regulatory approval)
- Synonyms
- Dihydroergocryptine; Dihydroergocryptine mesilate; Dihydroergocryptine mesylate (CHEMBL3707289)
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MixedOther
Model: Acute anoxia (asphyxia), including brain hypoxia
No abstract is available in the PubMed record, so the direction and magnitude of effect cannot be determined from the retrievable text.
Extraction: extract · Supplied extraction confidence: 0.2. Machine-extracted fields require source verification.
